INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical transplant approach offers hope for incurable liver cancer
Disease control Recruiting nowThis study is testing whether liver transplantation can help people with advanced bile duct cancer that can't be surgically removed. Patients first receive chemotherapy to control their cancer for at least 6 months, then receive a liver transplant if they remain eligible. The goa…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer drug targets specific protein in advanced tumors
Disease control Recruiting nowThis early-stage trial is testing a new drug called ALE.P03 in adults with advanced or spreading cancers that have a specific protein marker (CLDN1+). The study aims to find a safe and effective dose and see if the drug can shrink tumors. It will enroll 180 patients with cancers …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Liver cancer patients test home recovery after treatment
Disease control Recruiting nowThis study is testing whether patients with primary liver cancer can safely receive their artery-based treatments and recover at home instead of staying in the hospital. It will compare patient satisfaction, safety, and costs between the two care approaches over seven months. The…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New pump could bring powerful liver cancer treatment closer to home
Disease control Recruiting nowThis study is testing the safety and practicality of a special pump that delivers chemotherapy directly to the liver for people with colorectal cancer or bile duct cancer that has spread to the liver. Researchers want to see if the pump can be safely used and if patients can get …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Michael J Cavnar, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for inoperable liver cancer: testing Direct-Attack therapies
Disease control Recruiting nowThis study is for people with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery right away. It aims to see if combining standard chemotherapy with one of two treatments that deliver therapy directly to the liver can help control the ca…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat liver cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, pemigatinib and durvalumab, can help control a specific type of advanced bile duct cancer that has a particular genetic change (FGFR-2). It is for adults whose cancer has worsened after initial treatment. The main goal is to see …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Mehmet Akce • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
One-Shot radiation: new MRI tech aims to zap liver tumors in a single visit
Disease control Recruiting nowThis study is testing a new, faster way to deliver precise radiation treatment for liver cancer. It uses real-time MRI scans to guide the radiation beam and aims to complete the entire treatment in a single session, without needing a separate planning scan. The main goal is to se…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New hope for tough liver cancer: targeted chemo pump tested
Disease control Recruiting nowThis study is for people with a type of bile duct cancer in the liver that cannot be removed by surgery. It compares standard chemotherapy to the same chemotherapy plus a second drug delivered directly to the liver via a special pump. The goal is to see if the combined treatment …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC